-
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala
Mar 10, 2025, 14:00 PM -
Comorbidity Burden Among Patients with Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD
Mar 10, 2025, 14:00 PM -
Number Needed to Treat and Associated Costs Per Additional Responder of Biologic Therapies in Adult Patients With Moderate To Severe Atopic Dermatitis
Mar 10, 2025, 14:00 PM -
Assessing Antipsychotic Adherence in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real-World Data
Mar 10, 2025, 14:00 PM -
Imputing Breast Cancer Stage in a Large EHR Dataset: Light Gradient Boosting Machine Algorithm and Explainable Artificial Intelligence
Mar 10, 2025, 14:00 PM -
Health Disparities in In-Hospital Mortality Related to Bloodstream Infections in the US: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies
Mar 10, 2025, 14:00 PM -
Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia
Mar 10, 2025, 14:00 PM -
Healthcare Resource Optimization of Different Formulations: Daratumumab SC Compared To Daratumumab IV for Treating Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Stage IV Endometrial Cancer Patients with Lung Metastasis: A SEER-Based Cohort Study
Mar 10, 2025, 14:00 PM -
Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis
Mar 10, 2025, 14:00 PM -
Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age
Mar 10, 2025, 14:00 PM -
Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial
Mar 10, 2025, 14:00 PM -
Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing
Mar 10, 2025, 14:00 PM -
Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making
Mar 10, 2025, 14:00 PM -
Real-World (rw) Early Clinical Endpoints for Patients with Resectable Non-Small Cell Lung Cancer (NSCLC): A Database Evaluation Study
Mar 10, 2025, 14:00 PM -
Double Immune Checkpoint Inhibition as First-Line Treatment for BRAF-Mutant Advanced Melanoma: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective
Mar 10, 2025, 14:00 PM
